Eric Richman serves as an Independent Director for multiple companies, including PolarityTE, Tempo Therapeutics, MicroHealth, and LabConnect, alongside a position as Director at Gain Therapeutics and co-founder of Horizon Infusions. Richman previously held the role of Director at ADMA Biologics, Inc. and Venture Partner at Brace Pharma Capital. Richman's leadership experience includes serving as President and CEO at PharmAthene, Inc., as well as a Director at American Bank. Richman earned a BS in Biomedical Science from CUNY School of Medicine and an MBA in Finance and International Marketing from Thunderbird School of Global Management.